Explosifs Produits Chimiques S.A. | Mid-cap | Basic Materials

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 469.5M
Total Liabilities 297.1M
Shareholders Equity 172.4M
Debt to Equity 1.72

Cash Flow Metrics

Revenue & Profitability Trend

Explosifs Produits Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i490.2M482.3M467.5M377.6M338.5M
Cost of Goods Sold i311.7M325.5M324.1M248.6M226.8M
Gross Profit i178.4M156.7M143.4M129.0M111.8M
Gross Margin % i36.4%32.5%30.7%34.2%33.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i--18.6M16.4M14.1M
Other Operating Expenses i6.3M8.5M2.3M12.1M13.6M
Total Operating Expenses i6.3M8.5M21.0M28.5M27.7M
Operating Income i21.3M19.4M20.5M8.9M1.6M
Operating Margin % i4.3%4.0%4.4%2.4%0.5%
Non-Operating Items
Interest Income i0141.0K105.0K36.0K0
Interest Expense i6.4M6.3M3.9M3.0M3.0M
Other Non-Operating Income-----
Pre-tax Income i29.0M26.6M22.8M12.2M-12.9M
Income Tax i4.1M3.7M3.8M5.4M5.2M
Effective Tax Rate % i14.2%14.0%16.7%44.7%0.0%
Net Income i24.9M22.9M19.0M6.7M-18.1M
Net Margin % i5.1%4.7%4.1%1.8%-5.4%
Key Metrics
EBITDA i65.5M60.5M51.2M39.0M27.4M
EPS (Basic) i-€10.16€8.40€3.17€-10.02
EPS (Diluted) i-€10.16€8.40€3.17€-10.02
Basic Shares Outstanding i-2101674210232518450611845061
Diluted Shares Outstanding i-2101674210232518450611845061

Income Statement Trend

Explosifs Produits Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i30.7M26.2M27.7M22.9M19.3M
Short-term Investments i-----
Accounts Receivable i120.9M125.6M137.2M116.7M96.2M
Inventory i62.0M54.2M60.4M39.5M29.4M
Other Current Assets11.2M10.8M9.4M9.1M8.6M
Total Current Assets i244.1M236.8M236.6M190.4M169.8M
Non-Current Assets
Property, Plant & Equipment i256.4M236.6M217.7M99.4M89.1M
Goodwill i27.8M23.0M23.4M22.6M17.5M
Intangible Assets i5.4M4.3M4.6M3.6M1.9M
Long-term Investments521.0K827.0K1.7M--
Other Non-Current Assets---23.0K213.0K
Total Non-Current Assets i225.5M208.9M193.1M173.6M165.9M
Total Assets i469.5M445.6M429.7M364.0M335.7M
Liabilities
Current Liabilities
Accounts Payable i83.5M75.2M95.2M74.0M63.2M
Short-term Debt i43.2M34.8M33.0M20.9M27.1M
Current Portion of Long-term Debt-----
Other Current Liabilities8.8M8.1M5.3M7.7M6.5M
Total Current Liabilities i193.0M177.1M187.8M157.5M148.9M
Non-Current Liabilities
Long-term Debt i63.2M83.2M82.7M65.6M65.5M
Deferred Tax Liabilities i2.3M1.7M1.8M1.5M1.3M
Other Non-Current Liabilities1.7M1.3M1.0M798.0K343.0K
Total Non-Current Liabilities i104.1M123.6M115.5M100.4M106.1M
Total Liabilities i297.1M300.7M303.3M257.9M255.0M
Equity
Common Stock i7.0M7.0M7.0M7.0M5.2M
Retained Earnings i23.4M21.3M17.7M5.9M-18.5M
Treasury Stock i2.5M2.7M2.5M--
Other Equity-----
Total Shareholders Equity i172.4M144.9M126.4M106.1M80.6M
Key Metrics
Total Debt i106.5M118.1M115.7M86.5M92.6M
Working Capital i51.1M59.7M48.8M32.9M20.9M

Balance Sheet Composition

Explosifs Produits Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i24.9M22.9M19.0M6.7M-18.1M
Depreciation & Amortization i-----
Stock-Based Compensation i2.7M259.0K190.0K709.0K0
Working Capital Changes i-1.7M-2.2M-42.5M-17.6M1.3M
Operating Cash Flow i34.0M26.4M-19.9M-7.4M-14.3M
Investing Activities
Capital Expenditures i-25.5M-16.9M-28.3M-15.1M-15.9M
Acquisitions i---175.0K-1.6M-
Investment Purchases i00-8.0K0-90.0K
Investment Sales i--000
Investing Cash Flow i-27.2M-16.5M-28.6M-18.2M-16.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-2.1M-88.0K---
Debt Issuance i4.0M11.6M43.5M4.0M28.4M
Debt Repayment i-21.0M-15.3M-25.1M-9.1M-42.1M
Financing Cash Flow i-32.7M-16.3M17.2M-2.8M-13.7M
Free Cash Flow i40.5M10.6M-8.5M12.1M23.7M
Net Change in Cash i-25.9M-6.5M-31.3M-28.5M-43.9M

Cash Flow Trend

Explosifs Produits Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 19.17
Forward P/E 10.94
Price to Book 2.47
Price to Sales 0.84

Profitability Ratios

Profit Margin 4.73%
Operating Margin 3.29%
Return on Equity 15.66%
Return on Assets 2.77%

Financial Health

Current Ratio 1.26
Debt to Equity 61.75
Beta 0.50

Per Share Data

EPS (TTM) €10.12
Book Value per Share €78.43
Revenue per Share €234.52

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
expl413.1M19.172.4715.66%4.73%61.75
Arkema S.A 4.8B25.160.782.93%2.39%50.89
Carbios S.A 164.9M-5.160.83-15.26%0.00%22.87
Lhyfe S.A.S 156.3M-5.352.17-33.53%82.53%111.86
Afyn SAS 68.8M-1.31-17.04%-6.08%6.29
Plasticos Compuestos 13.3M-1.00-1.20%-0.36%95.11

Financial data is updated regularly. All figures are in the company's reporting currency.